Skip to content

The effect of the Jujube syrup on mild atopic dermatitis

Investigating the effect of a Jujube extract syrup on mild to moderate atopic dermatitis in adult patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231118060097N1
Enrollment
40
Registered
2024-07-07
Start date
2024-08-22
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis. A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin, with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus.

Interventions

Intervention 1: Intervention group: Patients receive 14 ml of Jujube extract syrup, including aqueous extract of jujube, and viola odorata, divided into two parts in the morning and evening for 3 week

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with atopic dermatitis based on physical examination and confirmation by a dermatologist Absence of pregnancy and breastfeeding Age 18 and above Not having associated skin diseases Not having diseases such as immune disorders and cancer SCORAD less than 50

Exclusion criteria

Exclusion criteria: History of allergy to Jujube or Viola Consumption of systemic corticosteroid by the patient Failure to comply with the treatment protocol of drug use by the patient

Design outcomes

Primary

MeasureTime frame
Redness and erythema. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Dryness. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Excoriation. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.;Itching. Timepoint: 0, 3, 5 weeks. Method of measurement: SCORAD questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: 0, 3, 5 weeks. Method of measurement: DLQI questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mehrsharif

Mashhad University of Medical Sciences

Marysharif00@gmail.com+98 51 3884 8931

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026